CHARLES W NEWHALL III Insider Trading $SUPN SUPERNUS PHARMACEUTICALS, INC.
Get free email notifications about insider trading for CHARLES W NEWHALL III.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES W NEWHALL III. CHARLES W NEWHALL III is Director in PHARMOS CORP ($PARS) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in Workday, Inc. ($WDAY) and 10% Owner in INNERWORKINGS INC ($INWK) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in FUSION-IO, INC. ($FIO) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Echo Global Logistics, Inc. ($ECHO) and 10% Owner in Financial Engines, Inc. ($FNGN).
CHARLES W NEWHALL III in SUPERNUS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHARLES W NEWHALL III: Director
Holdings: 10,641,250 shares
Current Value: $262,306,813
Latest Transaction: Jan 23 2014
$SUPN Market Capitalization: $1.26B
$SUPN Previous Close: $24.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CHARLES W NEWHALL III in SUPERNUS PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FOLD, ECHO, FNGN, FIO, HPTX, INHX, INWK, PARS, SUPN, VG, WDAY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 23 2014 | SUPN | SUPERNUS PHARMACEU ... | NEWHALL CHARLES W III | Director | Option Exercise | A | 9.24 | 7,457 | 68,903 | 7,457 | |
| Feb 07 2013 | SUPN | SUPERNUS PHARMACEU ... | NEWHALL CHARLES W III | Director | Option Exercise | A | 7.90 | 8,722 | 68,904 | 8,722 | |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | NEWHALL CHARLES W III | Director | Option Exercise | C | 0.00 | 24,965,000 | 0 | 0 | |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | NEWHALL CHARLES W III | Director | Buy | P | 5.00 | 4,400,000 | 22,000,000 | 10,641,250 | 6.2 M to 10.6 M (+70.50 %) |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | NEWHALL CHARLES W III | Director | Buy | C | 0.00 | 6,241,250 | 0 | 6,241,250 | 0 to 6.2 M |
Page: 1